Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 15
December 2018
Volume 59, Issue 15
Open Access
Lens  |   December 2018
Epithelial-Mesenchymal Transdifferentiation in Pediatric Lens Epithelial Cells
Author Affiliations & Notes
  • Laura Wernecke
    Experimental Ophthalmology, Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
    Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Susanne Keckeis
    Experimental Ophthalmology, Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Nadine Reichhart
    Experimental Ophthalmology, Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Olaf Strauß
    Experimental Ophthalmology, Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Daniel J. Salchow
    Department of Ophthalmology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Correspondence: Daniel J. Salchow, Department of Ophthalmology Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Augustenburger Platz 1, Berlin 13353, Germany; [email protected]
Investigative Ophthalmology & Visual Science December 2018, Vol.59, 5785-5794. doi:https://doi.org/10.1167/iovs.18-23789
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Wernecke, Susanne Keckeis, Nadine Reichhart, Olaf Strauß, Daniel J. Salchow; Epithelial-Mesenchymal Transdifferentiation in Pediatric Lens Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2018;59(15):5785-5794. https://doi.org/10.1167/iovs.18-23789.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Posterior capsule opacification (PCO) is a complication after cataract surgery, particularly in children. Epithelial-mesenchymal transition (EMT) of lens epithelial cells, mediated by transforming growth factor beta (TGFβ), contributes to PCO. However, its pathogenesis in children is poorly understood. We correlated cell growth in culture with patient characteristics, studied gene expression of pediatric lens epithelial cells (pLEC), and examined the effects of TGFβ-2 on these cells in vitro.

Methods: Clinical characteristics of children with cataracts correlated with growth behavior of pLEC in vitro. mRNA expression of epithelial (αB-crystallin, connexin-43) and mesenchymal (αV-integrin, α-smooth muscle actin, collagen-Iα2, fibronectin-1) markers was quantified in pLEC and in cell line HLE-B3 in the presence and absence of TGFβ-2.

Results: Fifty-four anterior lens capsules from 40 children aged 1 to 180 months were obtained. Cell outgrowth occurred in 44% of the capsules from patients ≤ 12 months and in 33% of capsules from children aged 13 to 60 months, but in only 6% of capsules from children over 60 months. TGFβ-2 significantly upregulated expression of αB-crystallin (HLE-B3), αV-integrin (HLE-B3), collagen-Iα2, and fibronectin-1 (in pLEC and HLE-B3 cells).

Conclusions: Patient characteristics correlated with growth behavior of pLEC in vitro, paralleling a higher clinical incidence of PCO in younger children. Gene expression profiles of pLEC and HLE-B3 suggest that upregulation of αV-integrin, collagen-Iα2, and fibronectin-1 are involved in EMT.

Opacification of the lens (cataract) can significantly impair vision. Although more common in older adults, cataracts occur in childhood (congenital and juvenile cataracts). Congenital cataracts are responsible for 5% to 20% of cases of treatable blindness in children.1 Childhood cataracts may be isolated or in association with other entities, including trauma, infection, inflammation, and metabolic and syndromic disorders.1,2 A significant proportion of bilateral childhood cataracts is hereditary.3,4 Visually significant congenital cataracts are usually operated within the first few weeks of life to prevent refractory amblyopia.5 
Posterior capsule opacification (PCO), an obscuration of the lens capsule after cataract surgery, is especially common in young children. If extending centrally, visual axis opacification (VAO) may result and reduce vision. This postoperative complication has been reported in up to 44% of children within the first year after cataract surgery, and it occurs more frequently in younger children.6,7 Although surgical techniques such as a primary posterior capsulotomy and anterior vitrectomy reduce the risk for VAO in children, these surgical steps are associated with a higher risk of postoperative complications such as retinal detachment, cystoid macular edema, glaucoma, endophthalmitis, and inflammation.5,812 
The knowledge of the pathogenesis of PCO in children and its prevention remains limited. As it is virtually impossible to remove all lens epithelial cells during cataract surgery, remaining cells can undergo epithelial-mesenchymal transition (EMT), defined as a loss of polarity, cell-to-cell contact, and epithelial characteristics.13 Transformed cells may proliferate and migrate to the visual axis, where the resulting opacification can necessitate surgical intervention.14 
Transforming growth factor beta (TGFβ) appears to play a key role in the pathology of PCO in adults.15,16 In the aqueous humor of the anterior chamber, TGFβ is secreted as an inactive complex.17 In the eye, the isoform TGFβ-2 dominates and appears to be the most potent isoform to be associated with the development of PCO.15,17,18 It is thought that TGFβ is upregulated and activated by postoperative inflammation and that surgical complications may further increase its levels in the anterior chamber.15 
The signaling pathways of TGFβ in adult PCO are well described. In lens epithelial cells, activated TGFβ increases the expression of mesenchymal markers such as fibronectin-1 (FN1), α-smooth muscle actin (aSMA), and collagen-Iα2 (COL1A2).15,16,19 TGFβ also decreases the expression of epithelial markers such as αB-crystallin (CRYAB) and connexin-43 (Cx43) in cells undergoing EMT.15,16 Furthermore, PCO is associated with upregulated levels of α-integrin subunits (ITGAV), which are involved in TGFβ activation and signaling.20,21 The latent TGFβ complex is marked by a noncovalent association between propeptides and TGFβ.22 Recent reports suggest that αVβ6-integrin21 and other alpha integrins have the ability to disrupt this association, activating TGFβ and allowing it to interact with its receptor.20 Nevertheless, these findings are based only on the induction of EMT by TGFβ in animal cells,23,24 adult human lens epithelial cells,25 and human lens cell lines.26,27 Experimental studies that describe the molecular basics of pediatric lens epithelial cells (pLEC) are lacking. Since regrowth of the lens from pLEC was presented as a new therapeutic approach for pediatric cataract patients recently,28 a better understanding of the molecular pathomechanisms involved in the formation of PCO in children becomes more important. Due to the rarity of childhood cataracts, the pathogenesis and signaling cascades remain largely unexplored. 
In order to study the cellular characteristics of pLEC in culture, we established a protocol for cell culture. We then correlated patient characteristics with growth behavior of pLEC in vitro, and generated a gene expression profile to define the differentiation status of these cells. Confirmatory experiments were performed on the lens cell line HLE-B3. We then investigated the effect of TGFβ-2 on the gene expression profiles to study the molecular basis of EMT in pLEC in children. 
Methods
Patient Characteristics
Forty children (age 1 to 180 months) with uni- or bilateral cataracts presenting to the Department of Ophthalmology, Charité–Universitätsmedizin Berlin, participated in this study. The parents provided informed consent to participate in the study. The study protocol was approved by the ethics committee (institutional review board of Charité–Universitätsmedizin Berlin). All procedures involving human material were performed in accordance with current ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. 
The following clinical parameters were collected: age at cataract surgery, sex, laterality of cataract, type of cataract, etiology (e.g., family history of cataracts, presence of disorders related to cataract), and other ocular comorbidities such as strabismus and nystagmus. 
Cell Culture
Cultivation of Pediatric Lens Epithelial Cells
Fifty-four anterior lens capsules of 40 children were harvested during cataract surgery by means of manual curvilinear capsulorhexis (Fig. 1A). Modifying the method described by Ibaraki,29 we established a protocol to cultivate pLEC as follows: 
  1.  
    Anterior lens capsules of approximately 5-mm diameter with attached pLEC, obtained during cataract surgery in children, were immediately transported to the laboratory in balanced salt solution and were transferred to 35-mm culture wells (Eppendorf, Hamburg, Germany) within 30 minutes of collection.
  2.  
    After allowing them to rest for 5 minutes, the lens capsules were covered with 60 μL Dulbecco's modified Eagle's medium/F-12 (Sigma-Aldrich Corp., Schnelldorf, Germany) supplemented with 20% fetal calf serum (PAA Laboratories GmbH, Pasching, Austria) and 1% penicillin-streptomycin (Biochrom AG, Berlin, Germany) and secured at the bottom of the well with 12-mm glass coverslips. This concentration of serum has been described as optimal for culturing human lens epithelial cells.2932
  3.  
    Lens capsules were cultured at 37°C in a 5% CO2 atmosphere. Based on other studies, all cells were cultured at atmospheric oxygen levels.30,33,34 After 24 hours, 1 mL culture medium was carefully added to the culture plates.
  4.  
    The medium was changed every 3 days. At this stage, 16 capsules showed cell outgrowth and pLEC from six capsules were immediately used for analysis of mRNA expression. The remaining 10 capsules were subcultured on day 13 using Accutase (PAA) and transferred to a 12-well plate, while empty lens capsules were removed.
  5.  
    After reaching confluence in 4 to 6 days, pLEC were subcultured again and seeded on two culture plates.
  6.  
    Upon reaching a confluence of 70%, cells of six capsules were serum starved for 24 hours followed by stimulation with 10 ng/mL TGFβ-2 (Sigma-Aldrich Corp.) for 48 hours in serum-free medium to study its effect on the cells. Serum-free cells cultivated without TGFβ-2 served as the control. For comparison, each experiment and control was performed on samples of the same lens capsule (see step 5 above).
Figure 1
 
Gene expression profile of pediatric lens cells. (A) Manual capsulorhexis during cataract surgery on a child. The anterior lens capsule with the attached primary lens epithelial cells is harvested. (B) Cultivated pLEC were monitored by phase contrast microscopy on day 6 (objective ×20). Cells near the capsule were predominantly cuboid, whereas remote cells had an elongated character. (C) Quantitative RT-PCR was used to analyze mRNA expression for Cx43, CRYAB, aSMA, ITGAV, COL1A2, and FN1. TGFβ-2 (10 ng/mL for 48 hours) increased gene expression of COL1A2 and FN1 significantly (P < 0.05) in pLEC. GAPDH was selected as housekeeping gene. p0, passage 0; p2, passage 2.
Figure 1
 
Gene expression profile of pediatric lens cells. (A) Manual capsulorhexis during cataract surgery on a child. The anterior lens capsule with the attached primary lens epithelial cells is harvested. (B) Cultivated pLEC were monitored by phase contrast microscopy on day 6 (objective ×20). Cells near the capsule were predominantly cuboid, whereas remote cells had an elongated character. (C) Quantitative RT-PCR was used to analyze mRNA expression for Cx43, CRYAB, aSMA, ITGAV, COL1A2, and FN1. TGFβ-2 (10 ng/mL for 48 hours) increased gene expression of COL1A2 and FN1 significantly (P < 0.05) in pLEC. GAPDH was selected as housekeeping gene. p0, passage 0; p2, passage 2.
Cells were monitored daily by phase contrast microscopy, and capsules with cell outgrowth were correlated with patient characteristics. Anterior lens capsules without proliferation tendency were classified as proliferation negative. Other authors performed experiments using lens epithelial cells in passages 1–5.30,33,35 To ensure comparability, we used early-passage cells (passage 2) to study the effect of the growth factor TGFβ-2. To determine the properties of primary isolated pLEC, cells in passage 0 (p0) were used. 
Cultivation of HLE-B3 Cells
To validate the results obtained on pLEC, cells of the commercially available human lens epithelial cell line HLE-B3 (ATCC, Manassas, VA, USA) were cultured at 37°C in a 5% CO2 atmosphere in Eagle's Minimum Essential Medium (EMEM; ATCC) containing 20% fetal calf serum (PAA) and 1% penicillin-streptomycin (Biochrom AG). As in pLEC, gene expression profiles of serum-free HLE-B3 cells in the absence and presence of TGFβ-2 were studied. A short tandem repeat analysis certificate was provided by the manufacturer. 
RNA Isolation and Reverse Transcription
Due to the small number of pLEC obtained from the donor capsules, RNA of pLEC was isolated with a reagent (TRI-Reagent; Sigma-Aldrich Corp.) and a visible dye-labeled carrier (Pellet Paint; Novagen, San Diego, CA, USA). RNA was extracted from HLE-B3 cells in passage 5 to 9 using a kit (RNeasy Micro Kit; Qiagen, Hilden, Germany). 
In pLEC and HLE-B3 cells, a reverse transcription kit (QuantiTect; Qiagen) was used to synthesize cDNA. To eliminate genomic DNA contamination, 2 μL gDNA wipeout buffer was added to the samples. 
Quantitative Real-Time PCR and Gel Electrophoresis
Gene expression of pLEC and HLE-B3 cells was assessed by quantitative real-time PCR (qRT-PCR) using Rotor-Gene SYBR Green PCR Mix (Qiagen) on a real-time PCR cycler (Rotor-Gene Q; Qiagen). For analysis of each candidate gene, triplicates were prepared. Primers were designed using Primer-BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA). GAPDH was selected as internal control gene for relative quantification. Primers were obtained from Eurofins MWG Operon (Eurofins Genomics, Ebersberg, Germany). Primer sequences and expected product sizes are listed in Table 1
Table 1
 
Primer Sequences Used for mRNA Quantification by qRT-PCR
Table 1
 
Primer Sequences Used for mRNA Quantification by qRT-PCR
Data were analyzed with software (Rotor-Gene; Qiagen) and relative mRNA expression was calculated by employing the comparative CT method.36 
Gel electrophoresis was used to test for specific amplification and primer dimers. 
Molecular imager Chem Doc XRS (Biorad, Munich, Germany) allowed identification of PCR amplicons by their product size (see Supplementary Fig. S1). 
Immunocytochemistry (ICC)
At passage p0, pLEC, as well as stimulated and unstimulated HLE-B3 cells on glass coverslips, were fixed with 4% paraformaldehyde for 10 minutes at room temperature. After incubation in a blocking solution containing 5% BSA in Tris-buffered saline for 30 minutes, the following primary antibodies were applied overnight at 4°C: anti-actin, aSMA-Cy3 (1:500, mouse monoclonal; Sigma-Aldrich Corp.), and anti-fibronectin (1:250, mouse monoclonal; Sigma-Aldrich Corp.). For visualization of fibronectin, another incubation step at room temperature for 1 hour was added using the secondary antibody goat anti-mouse (AF546, 1:5000; Thermo Fisher, Darmstadt, Germany). The negative control was performed with HLE-B3 cells stained only with secondary antibody without primary antibody incubation (see Supplementary Fig. S2). Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich Corp.). Subsequently, coverslips were mounted onto glass slides and subjected to an Axio Imager 2 and Zen lite 2012 Software (Zeiss, Jena, Germany). Fluorescence signal analysis was performed by measuring color pixels per square micrometer of 13 cells per group. To determine the mean corrected total cell fluorescence (CTCF) the following formula was used37:  
\(\def\upalpha{\unicode[Times]{x3B1}}\)\(\def\upbeta{\unicode[Times]{x3B2}}\)\(\def\upgamma{\unicode[Times]{x3B3}}\)\(\def\updelta{\unicode[Times]{x3B4}}\)\(\def\upvarepsilon{\unicode[Times]{x3B5}}\)\(\def\upzeta{\unicode[Times]{x3B6}}\)\(\def\upeta{\unicode[Times]{x3B7}}\)\(\def\uptheta{\unicode[Times]{x3B8}}\)\(\def\upiota{\unicode[Times]{x3B9}}\)\(\def\upkappa{\unicode[Times]{x3BA}}\)\(\def\uplambda{\unicode[Times]{x3BB}}\)\(\def\upmu{\unicode[Times]{x3BC}}\)\(\def\upnu{\unicode[Times]{x3BD}}\)\(\def\upxi{\unicode[Times]{x3BE}}\)\(\def\upomicron{\unicode[Times]{x3BF}}\)\(\def\uppi{\unicode[Times]{x3C0}}\)\(\def\uprho{\unicode[Times]{x3C1}}\)\(\def\upsigma{\unicode[Times]{x3C3}}\)\(\def\uptau{\unicode[Times]{x3C4}}\)\(\def\upupsilon{\unicode[Times]{x3C5}}\)\(\def\upphi{\unicode[Times]{x3C6}}\)\(\def\upchi{\unicode[Times]{x3C7}}\)\(\def\uppsy{\unicode[Times]{x3C8}}\)\(\def\upomega{\unicode[Times]{x3C9}}\)\(\def\bialpha{\boldsymbol{\alpha}}\)\(\def\bibeta{\boldsymbol{\beta}}\)\(\def\bigamma{\boldsymbol{\gamma}}\)\(\def\bidelta{\boldsymbol{\delta}}\)\(\def\bivarepsilon{\boldsymbol{\varepsilon}}\)\(\def\bizeta{\boldsymbol{\zeta}}\)\(\def\bieta{\boldsymbol{\eta}}\)\(\def\bitheta{\boldsymbol{\theta}}\)\(\def\biiota{\boldsymbol{\iota}}\)\(\def\bikappa{\boldsymbol{\kappa}}\)\(\def\bilambda{\boldsymbol{\lambda}}\)\(\def\bimu{\boldsymbol{\mu}}\)\(\def\binu{\boldsymbol{\nu}}\)\(\def\bixi{\boldsymbol{\xi}}\)\(\def\biomicron{\boldsymbol{\micron}}\)\(\def\bipi{\boldsymbol{\pi}}\)\(\def\birho{\boldsymbol{\rho}}\)\(\def\bisigma{\boldsymbol{\sigma}}\)\(\def\bitau{\boldsymbol{\tau}}\)\(\def\biupsilon{\boldsymbol{\upsilon}}\)\(\def\biphi{\boldsymbol{\phi}}\)\(\def\bichi{\boldsymbol{\chi}}\)\(\def\bipsy{\boldsymbol{\psy}}\)\(\def\biomega{\boldsymbol{\omega}}\)\(\def\bupalpha{\unicode[Times]{x1D6C2}}\)\(\def\bupbeta{\unicode[Times]{x1D6C3}}\)\(\def\bupgamma{\unicode[Times]{x1D6C4}}\)\(\def\bupdelta{\unicode[Times]{x1D6C5}}\)\(\def\bupepsilon{\unicode[Times]{x1D6C6}}\)\(\def\bupvarepsilon{\unicode[Times]{x1D6DC}}\)\(\def\bupzeta{\unicode[Times]{x1D6C7}}\)\(\def\bupeta{\unicode[Times]{x1D6C8}}\)\(\def\buptheta{\unicode[Times]{x1D6C9}}\)\(\def\bupiota{\unicode[Times]{x1D6CA}}\)\(\def\bupkappa{\unicode[Times]{x1D6CB}}\)\(\def\buplambda{\unicode[Times]{x1D6CC}}\)\(\def\bupmu{\unicode[Times]{x1D6CD}}\)\(\def\bupnu{\unicode[Times]{x1D6CE}}\)\(\def\bupxi{\unicode[Times]{x1D6CF}}\)\(\def\bupomicron{\unicode[Times]{x1D6D0}}\)\(\def\buppi{\unicode[Times]{x1D6D1}}\)\(\def\buprho{\unicode[Times]{x1D6D2}}\)\(\def\bupsigma{\unicode[Times]{x1D6D4}}\)\(\def\buptau{\unicode[Times]{x1D6D5}}\)\(\def\bupupsilon{\unicode[Times]{x1D6D6}}\)\(\def\bupphi{\unicode[Times]{x1D6D7}}\)\(\def\bupchi{\unicode[Times]{x1D6D8}}\)\(\def\buppsy{\unicode[Times]{x1D6D9}}\)\(\def\bupomega{\unicode[Times]{x1D6DA}}\)\(\def\bupvartheta{\unicode[Times]{x1D6DD}}\)\(\def\bGamma{\bf{\Gamma}}\)\(\def\bDelta{\bf{\Delta}}\)\(\def\bTheta{\bf{\Theta}}\)\(\def\bLambda{\bf{\Lambda}}\)\(\def\bXi{\bf{\Xi}}\)\(\def\bPi{\bf{\Pi}}\)\(\def\bSigma{\bf{\Sigma}}\)\(\def\bUpsilon{\bf{\Upsilon}}\)\(\def\bPhi{\bf{\Phi}}\)\(\def\bPsi{\bf{\Psi}}\)\(\def\bOmega{\bf{\Omega}}\)\(\def\iGamma{\unicode[Times]{x1D6E4}}\)\(\def\iDelta{\unicode[Times]{x1D6E5}}\)\(\def\iTheta{\unicode[Times]{x1D6E9}}\)\(\def\iLambda{\unicode[Times]{x1D6EC}}\)\(\def\iXi{\unicode[Times]{x1D6EF}}\)\(\def\iPi{\unicode[Times]{x1D6F1}}\)\(\def\iSigma{\unicode[Times]{x1D6F4}}\)\(\def\iUpsilon{\unicode[Times]{x1D6F6}}\)\(\def\iPhi{\unicode[Times]{x1D6F7}}\)\(\def\iPsi{\unicode[Times]{x1D6F9}}\)\(\def\iOmega{\unicode[Times]{x1D6FA}}\)\(\def\biGamma{\unicode[Times]{x1D71E}}\)\(\def\biDelta{\unicode[Times]{x1D71F}}\)\(\def\biTheta{\unicode[Times]{x1D723}}\)\(\def\biLambda{\unicode[Times]{x1D726}}\)\(\def\biXi{\unicode[Times]{x1D729}}\)\(\def\biPi{\unicode[Times]{x1D72B}}\)\(\def\biSigma{\unicode[Times]{x1D72E}}\)\(\def\biUpsilon{\unicode[Times]{x1D730}}\)\(\def\biPhi{\unicode[Times]{x1D731}}\)\(\def\biPsi{\unicode[Times]{x1D733}}\)\(\def\biOmega{\unicode[Times]{x1D734}}\)\begin{equation}CTCF = Integrated\ Density - \left( {{\it{Area\ of\ selected\ cell}} \times {\it{Mean\ fluorescence\ of\ background\ readings}}} \right).\end{equation}
 
Pixel analysis was done with ImageJ 2.0 software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health).38 
Statistical Analysis
All experiments were performed at least three times. Statistical analysis was done with statistical software (GraphPad Prism 7; GraphPad Software, Inc., La Jolla, CA, USA). First, the ROUT method was employed to detect outliers. Normality was assessed using the Shapiro-Wilk test. 
To explore statistical significance, Fisher exact test, χ2 test, Student's t-test or Mann-Whitney U test were performed, with a P value < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001) considered as statistically significant. Box plot whiskers represent the range, and mean ± standard error of the mean was reported. 
Results
Patient Characteristics
Of 40 children with cataracts included in this study, 38% were female and 68% were diagnosed with bilateral cataracts (Table 2). In 25% of cases, family history was positive for childhood cataracts. Associated diagnoses such as chromosomal anomalies, craniofacial syndromes, dermatologic disorders, aniridia, or uveitis were noted in 23% of patients. In 53% of children, the etiology of the cataracts remained unclear (Table 2). 
Table 2
 
Characteristics of 40 Child Study Participants With Cataracts
Table 2
 
Characteristics of 40 Child Study Participants With Cataracts
Patient Characteristics and Cell Outgrowth
Of the 54 harvested anterior capsules, cell outgrowth was observed in 16 (30%). Gender did not affect the likelihood of cell outgrowth. While 44% of capsules from children ≤12 months of age at the time of surgery showed cell outgrowth, this was the case in 33% of capsules from children aged 13 to 60 months and in only 1 of 17 capsules (6%) from a child older than 60 months (Fig. 2A; Table 3). There was a significant association between age at cataract surgery and cell outgrowth in vitro (χ2 = 7.153; df = 2; P = 0.03). 
Figure 2
 
Frequency distribution of properties of all collected capsules versus capsules with outgrowth of pLEC. (A) Effect of age at time of surgery on outgrowth of pLEC in culture. Of capsules showing cell growth, 69% came from children 12 months or younger, 25% of children aged 13–60 months, and the remaining 6% from children older than 60 months. (B) Effect of cataract etiology on outgrowth of pLEC in culture. (C) Effect of clinical type of cataract on outgrowth of pLEC in culture. APC, anterior polar cataract; CC, complex cataract; NOS, not otherwise specified; PFV, persistent fetal vasculature; PPC, posterior polar cataract; PSC, posterior subcapsular cataract; TC, total cataract; ZC, zonular cataract.
Figure 2
 
Frequency distribution of properties of all collected capsules versus capsules with outgrowth of pLEC. (A) Effect of age at time of surgery on outgrowth of pLEC in culture. Of capsules showing cell growth, 69% came from children 12 months or younger, 25% of children aged 13–60 months, and the remaining 6% from children older than 60 months. (B) Effect of cataract etiology on outgrowth of pLEC in culture. (C) Effect of clinical type of cataract on outgrowth of pLEC in culture. APC, anterior polar cataract; CC, complex cataract; NOS, not otherwise specified; PFV, persistent fetal vasculature; PPC, posterior polar cataract; PSC, posterior subcapsular cataract; TC, total cataract; ZC, zonular cataract.
Table 3
 
Properties of the Capsules Included in the Study Regarding Patients' Features
Table 3
 
Properties of the Capsules Included in the Study Regarding Patients' Features
Outgrowth of pLEC was observed in 43% of the capsules obtained from patients with a positive family history for childhood cataract, 36% of capsules from children with cataracts associated with other entities, and 21% of capsules from patients with idiopathic cataracts (Fig. 2B, Table 3). 
As for the type of cataract, cell outgrowth was observed in 8/10 capsules from lenses with total cataracts, in 1/2 lenses with posterior polar cataracts, and in 2/3 lenses with persistent fetal vasculature (PFV). Two of 13 capsules with zonular cataract, 1/9 with complex cataract, and 2/9 capsules without specified cataract morphology showed cell outgrowth. Capsules from lenses with other types of cataracts did not show cell outgrowth (Fig. 2C; Table 3). There was a significant association between cataract type and cell growth in vitro (χ2 = 20.89; df = 7; P = 0.004). 
mRNA Expression of Primary pLEC Versus pLEC in Passage 2
ICC and qRT-PCR were performed to investigate the molecular properties of the primary isolated pLEC (p0). In order to determine possible changes caused by the cell culturing and passaging, mRNA expressions were compared with pLEC in passage 2. 
Subculturing did not have significant effects on mRNA expression of Cx43, aSMA, and ITGAV. However, there was a significant increase in mRNA expression of COL1A2 (P = 0.005, np0 = 6, np2 = 9) and FN1 (P = 0.0009, np0 = 6, np2 = 10) of cells in passage 2 compared to primary isolated pLEC (Fig. 1C). mRNA expression levels of CRYAB showed a significant reduction during subculturing (P = 0.009, np0 = 6, np2 = 9). Immunocytochemistry confirmed expression of mesenchymal markers aSMA and FN1 as proteins in primary isolated pLEC (see Supplementary Fig. S3). 
Effect of TGFβ-2 on mRNA Expression in pLEC
The effect of TGFβ-2 on pLEC was examined at passage 2 (Fig. 1B). There was a significant increase in mRNA expression of COL1A2 (P = 0.003, ncontrol = 9, nTGFβ-2 = 5) and FN1 (P = 0.0009, ncontrol = 10, nTGFβ2 = 6) in response to TGFβ-2 (Fig. 1C). However, TGFβ-2 stimulation did not have a significant effect on mRNA expression of ITGAV, Cx43, and aSMA. Although mRNA expression of CRYAB in pLEC was the highest of all investigated genes, no significant change after stimulation with TGFβ-2 was observed (Fig. 1C). 
Effect of TGFβ-2 on mRNA Expression and Immunocytochemistry in HLE-B3
Stimulation of HLE-B3 cells (Fig. 3A) with TGFβ-2 significantly increased mRNA expression of CRYAB (P = 0.0003, n = 9), ITGAV (P = 0.01, n = 9), COL1A2 (P = 0.0002, n = 9), and FN1 (P < 0.0001, n = 9) (Fig. 3B). As in pLEC, TGFβ-2 did not significantly affect expression of Cx43 and aSMA (Fig. 3B). Stimulated and unstimulated cells showed comparable levels fluorescence signals from staining of αSMA protein (Fig. 4A, C), while the protein expression of FN appeared significantly increased in the immunofluorescence staining in response to TGFβ-2 (P = 0.009, n = 13) (Fig. 4B, C). 
Figure 3
 
Effects of TGFβ-2 on HLE-B3 cells. (A) Phase contrast microscopy of cell line HLE-B3 in passage 5 (objective ×20). Scale bar: 1 mm. (B) Relative mRNA expression of all investigated genes in absence and presence of 10 ng/mL TGFβ-2. CRYAB, ITGAV, COL1A2, and FN1 were significantly increased after stimulation with TGFβ-2 for 48 hours (P < 0.05).
Figure 3
 
Effects of TGFβ-2 on HLE-B3 cells. (A) Phase contrast microscopy of cell line HLE-B3 in passage 5 (objective ×20). Scale bar: 1 mm. (B) Relative mRNA expression of all investigated genes in absence and presence of 10 ng/mL TGFβ-2. CRYAB, ITGAV, COL1A2, and FN1 were significantly increased after stimulation with TGFβ-2 for 48 hours (P < 0.05).
Figure 4
 
Immunocytochemistry of HLE-B3 cells. Immunocytochemistry of HLE-B3 cells stained with antibodies against αSMA (A) and FN (B) in absence and presence of 10 ng/mL TGFβ-2. Nuclei were stained with DAPI. Mean corrected cell fluorescence of FN was significantly increased by TGFβ-2 (C), P < 0.05. Scale bar: 50 μm.
Figure 4
 
Immunocytochemistry of HLE-B3 cells. Immunocytochemistry of HLE-B3 cells stained with antibodies against αSMA (A) and FN (B) in absence and presence of 10 ng/mL TGFβ-2. Nuclei were stained with DAPI. Mean corrected cell fluorescence of FN was significantly increased by TGFβ-2 (C), P < 0.05. Scale bar: 50 μm.
Comparison of mRNA Expression in Primary pLEC and HLE-B3
In unstimulated primary pLEC (p0), total mRNA levels were higher than in unstimulated HLE-B3 cells for most investigated genes. Particularly, mRNA expressions of COL1A2 (10-fold), CRYAB (194-fold), and aSMA (15-fold) were higher in pLEC than in HLE-B3 cells; mRNA expressions of Cx43 (4-fold) and ITGAV (3-fold) were moderately higher (Fig. 5A). The higher expression rates of these genes were associated with significantly higher mRNA levels of TGFβ-2 in primary pLEC compared to HLE-B3 cells (P = 0.0005, np0 = 5, nHLE-B3 = 6) (Fig. 5B). Primary isolated pLEC showed lower mRNA levels of FN1 (0.3-fold) compared to unstimulated HLE-B3 cells. 
Figure 5
 
Fold expression of unstimulated primary pLEC and unstimulated HLE-B3 cells. (A) Fold expression of COL1A2, CRYAB, and aSMA are up to 194-fold higher in primary pLEC (p0) compared to HLE-B3. mRNA expression of Cx43 and ITGAV are up to 4-fold higher in primary pLEC compared to HLE-B3, while expression of FN1 was lower in primary pLEC (p0). mRNA expression of HLE-B3 was normalized to 1. (B) Relative mRNA expression of TGFβ-2 was significant higher in primary isolated pLEC (p0) compared to HLE-B3 cells (P < 0.05).
Figure 5
 
Fold expression of unstimulated primary pLEC and unstimulated HLE-B3 cells. (A) Fold expression of COL1A2, CRYAB, and aSMA are up to 194-fold higher in primary pLEC (p0) compared to HLE-B3. mRNA expression of Cx43 and ITGAV are up to 4-fold higher in primary pLEC compared to HLE-B3, while expression of FN1 was lower in primary pLEC (p0). mRNA expression of HLE-B3 was normalized to 1. (B) Relative mRNA expression of TGFβ-2 was significant higher in primary isolated pLEC (p0) compared to HLE-B3 cells (P < 0.05).
Discussion
Pediatric cataracts are rare,2,4,39 and research concerning the pathogenesis of both childhood cataract pathogenesis and PCO is limited, making therapeutic strategies difficult to develop. We provide insight into the pathophysiology of after-cataracts in children, which could serve as basis for future research to better understand the molecular mechanisms of this process and its prophylaxis. 
Patient Characteristics Affect Growth Behavior of Cells in Vitro
The purpose of this study was to establish a standardized protocol for cell culture of pediatric pLEC and to correlate cell outgrowth with clinical characteristics. Using the established cell-culturing protocol, 16 of the 54 capsules showed outgrowth of cells. We found that pLEC from lens capsules from younger children more often showed cell outgrowth in culture than did those from older children. This in vitro finding agrees with clinical experience that young age is a risk factor for PCO after pediatric cataract surgery.7 
Cataract type also affected pLEC outgrowth. While cell outgrowth in vitro happened in most capsules from lenses with a total cataract, PFV, or a posterior polar cataract, it occurred less frequently in capsules from zonular and complex cataracts. Capsules from anterior polar cataracts and posterior subcapsular cataract showed no cell outgrowth. 
Of note, cataract type is often related to patient age at surgery. For example, it is likely that denser (total) cataracts are diagnosed and operated on earlier than for subtler ones. A larger number of cases would be desirable, and future research may further study age and type of cataract as factors affecting behavior of pLEC in cell culture. 
A recent report suggested that regrowth of the lens from pLEC remaining in the lens capsule at the time of surgery may be possible.28 While this approach has the potential to revolutionize current concepts on optical rehabilitation after cataract surgery in children, the validity and reproducibility of this strategy remains to be confirmed. Our results would suggest that cell outgrowth may be more frequent in younger children with total cataracts, but whether a regenerated lens is sufficiently clear needs to be confirmed in clinical studies. However, understanding the cellular mechanisms underlying proliferation of pLEC in children is a prerequisite for the evaluation and implementation of novel therapeutic approaches for pediatric cataracts. 
Effect of TGFβ on pLEC
EMT is thought to be involved in the development of after-cataracts in adults.16 Our data support the hypothesis that the same mechanism applies for pLEC. Prior research described the induction of EMT by TGFβ in rat lens cells,23,24 adult human lens epithelial cells,25 and human lens cell lines26,27 as a characteristic feature of after-cataract formation.40 In after-cataract formation, TGFβ is known to act via the well-studied SMAD cascade and various SMAD independent signaling pathways.19,4043 EMT is characterized by an increased expression of α-smooth muscle actin, collagen-I, integrins, fibronectin, and other proteins considered to be mesenchymal markers. Conversely, epithelial markers are downregulated in the presence of TGFβ.23,24,4446 It can be assumed that this growth factor has comparable effects on pediatric lens cells. However, to our knowledge, no studies have qualified the influence of TGFβ-2 on these cells. Building on these studies, the present work describes the response of pediatric lens cells to TGFβ-2 that, however, might differ in its mechanism from that of adult EMT. 
We found an increased mRNA expression of extracellular matrix genes in presence of TGFβ-2 in pLEC. Stimulation with TGFβ-2 promoted an intense mRNA upregulation of FN1 and COL1A2 as features of a myofibroblastic transformation in pLEC. 
FN, an extracellular matrix protein, is reported to be involved in EMT.16,47 It was found to accumulate in experimental PCO, specifically in anterior subcapsular plaques in vitro16 and appears to be essential for integrin-promoted activation of TGFβ.47 Moreover, FN supports migration of rabbit lens epithelial cells in vitro and therefore might promote migration of lens epithelial cells to the posterior lens capsule.48 Consistent with these findings, pLEC showed significantly upregulated mRNA levels of FN1 in response to TGFβ-2. It appears likely that this pathway is involved in the formation of PCO, and it may be particularly responsible for fibrotic types of PCO in children. 
We demonstrated that TGFβ-2-mediated upregulation of mRNA for COL1A2 also occurs in pLEC. This substantiates previous immunohistologic studies identifying collagen-I-rich cells in congenital cataracts.49 In general, collagen-I is involved in TGFβ-related diseases such as idiopathic lung fibrosis, systemic sclerosis, and certain types of cancer.50,51 Overexpression of COL1A2 in pediatric lens cells with its fibrotic and migrating patterns may contribute to high incidence of PCO and VAO in children. 
TGFβ-induced upregulation of aSMA has been reported as a key factor in EMT.16,46 However, we found that TGFβ-2 had no significant effect on aSMA expression in pLEC or in HLE-B3 cells. The most likely explanation is that TGFβ signaling in juvenile cataract differs from that in adult cataract. TGFβ-mediated stimulation of aSMA expression appears to be age dependent.52 A lower proportion of advanced glycation end products in lens epithelial cells of younger donors may be associated with a weaker TGFβ-dependent effect on aSMA expression.52 The exact underlying mechanism of this TGFβ-mediated aSMA expression has not yet been identified. Although TGFβ may induce the expression of aSMA directly, indirect pathways and interactions with other TGFβ-induced proteins should be considered.53 In our study, a lack of TGFβ-2 effect on mRNA expression of aSMA might result from already elevated mRNA levels of aSMA in pLEC so that TGFβ-2 may not further upregulate this gene.54 Finally, it is important to note that variations in experimental methodology may affect stimulation results. Further research into delineating the underlying mechanisms is necessary. 
Detectable basal gene expression rates in primary pLEC for mesenchymal markers in the absence of TGFβ-2 suggest that these cells may have lost their epithelial features to some extent. These changes could be caused by an overexpression of TGFβ in congenital cataracts55,56 or an increased level of TGFβ following cataract surgery.57 Indeed, our study demonstrated higher basal expression rates of TGFβ-2 in pLEC compared to HLE-B3 cells. Stimulation of pLEC with TGFβ-2 further led to a significant increase in mRNA expression of mesenchymal genes, COL1A2 and FN1, implying transdifferentiation toward myofibroblastic characteristics. Interestingly, there was no significant concomitant reduction of epithelial markers in response to TGFβ-2. This is in line with the clinical observation that lens epithelial cells continue to produce lens material while proliferating and migrating on the remaining lens capsule. It remains to be demonstrated if success of recent therapeutic approaches such as regeneration of the lens from pLEC is limited by the transdifferentiation status of these cells. FN1 and COL1A2 seem to be characteristic genes in EMT in pLEC, so they can be recommended as potential targets to reduce PCO in children. 
As a limitation, one should consider that qRT-PCR measures gene expression but does not reflect changes on the protein level. The main obstacle to quantitative protein levels by Western blotting was the limited number of pLEC and the low amount of RNA per harvested lens capsule. Moreover, mRNA expression was investigated 48 hours after stimulation with TGFβ-2. One should consider that gene expression may vary at different times. Nevertheless, qRT-PCR is a highly reproducible and sensitive method, allowing quantification of specific DNA sequences.58,59 
Similar Effect of TGFβ-2 in HLE-B3 and pLEC
Consistent with findings in pLEC, we found TGFβ-2-induced gene expression profiles compatible with EMT in HLE-B3 cells. These cells served as a control for the experimental setup used to analyze pediatric lens cells. TGFβ-2 promoted a significant upregulation of ITGAV, FN1, and COL1A2 gene expression in HLE-B3 compared to untreated cells. Contrary to the well-studied effects of TGFβ-2 on mesenchymal markers,16,21,23,24,44 the present study also detected a significant upregulation of CRYAB in HLE-B3 cells after stimulation with TGFβ-2. With its chaperone-like and heat-shock protein activity, α-crystallin suppresses stress-induced cell death and lenticular protein aggregation and therefore preserves transparency of the lens.60,61 Overexpression of CRYAB under conditions of stress contributes to increased stress resistance of cells.62 Moreover, mutations in the α-crystallin gene cause congenital cataracts.63 Intriguingly, CRYAB also appears to be involved in EMT.62 One study found that depletion of CRYAB by siRNA has reduced TGFβ-induced mesenchymal changes in lens cells.62 It is possible that TGFβ-2 increases the expression of CRYAB, which subsequently results in an increased expression of EMT genes,62 and that increased CRYAB levels lead to an increased nuclear localization of Smad4, which induces mesenchymal genes and increased proliferative and migratory capacity.62,64 We detected high basal expression levels of CRYAB in pLEC and a TGFβ-2-promoted mRNA elevation of CRYAB in cell line HLE-B3. Whether this was due to an abortive protective mechanism of α-crystallin in lens cells undergoing EMT or whether high CRYAB levels contribute to the pathogenesis of PCO due to their antiapoptotic properties remains unclear.65 
We show that pLEC and HLE-B3 cells respond similarly to stimulation with TGFβ-2 with respect to mesenchymal markers FN1 and COL1A2, but that total expression rates of most examined genes were considerably higher in pLEC. This may reflect the greater vitality and metabolic activity of pLEC in children compared with the cell line. Changes in molecular expression cell lines can occur due to subculturing and growth medium composition. HLE-B3 cells are, although lens cells, not native cells and may not accurately reflect the behavior of pLEC. 
We found that pLEC from younger children were more likely to grow in cell cultures. These cells exhibit a gene expression profile that indicates a phenotypic shift from epithelial to mesenchymal properties (EMT). In the light of recent approaches for pediatric cataracts, our findings may help design research to better understand the molecular mechanisms involved in the formation of PCO. 
Acknowledgments
The authors thank Gabriele Fels (Charité, Universitätsmedizin Berlin) for technical support and Eckart Bertelmann (Charité, Universitätsmedizin Berlin) for providing lens capsules. 
Supported by the Marie-Luise-Geissler-Stiftung (Berlin, Germany), the German Research Foundation (DFG), and the Open Access Publication Fund of Charité - Universitätsmedizin Berlin. 
Disclosure: L. Wernecke, None; S. Keckeis, None; N. Reichhart, None; O. Strauß, None; D.J. Salchow, None 
References
Zetterström C, Lundvall A, Kugelberg M. Cataracts in children. J Cataract Refract Surg. 2005; 31: 824–840.
Trumler AA. Evaluation of pediatric cataracts and systemic disorders. Curr Opin Ophthalmol. 2011; 22: 365–379.
Zetterström C, Kugelberg M. Paediatric cataract surgery. Acta Ophthalmol Scand. 2007; 85: 698–710.
Wirth MG, Russell-Eggitt IM, Craig JE, Elder JE, Mackey DA. Aetiology of congenital and paediatric cataract in an Australian population. Br J Ophthalmol. 2002; 86: 782–786.
Lim ME, Buckley EG, Prakalapakorn SG. Update on congenital cataract surgery management. Curr Opin Ophthalmol. 2017; 28: 87–92.
Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol. 1992; 37: 73–116.
Jensen AA, Basti S, Greenwald MJ, Mets MB. When may the posterior capsule be preserved in pediatric intraocular lens surgery? Ophthalmology. 2002; 109: 324–327; discussion 328.
Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR; Infant Aphakia Treatment Study Group. Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology. 2011; 118: 2330–2334.
Hager T, Schirra F, Seitz B, Käsmann-Kellner B. Treatment of pediatric cataracts. Part 2: IOL implantation, postoperative complications, aphakia management and postoperative development [in German]. Ophthalmologe. 2013; 110: 179–190.
Whitman MC, Vanderveen DK. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014; 29: 414–420.
Medsinge A, Nischal KK. Pediatric cataract: challenges and future directions. Clin Ophthalmol. 2015; 9: 77–90.
Vasavada AR, Praveen MR, Tassignon MJ, et al. Posterior capsule management in congenital cataract surgery. J Cataract Refract Surg. 2011; 37: 173–193.
Martinez G, de Iongh RU. The lens epithelium in ocular health and disease. Int J Biochem Cell Biol. 2010; 42: 1945–1963.
Nibourg LM, Gelens E, Kuijer R, Hooymans JM, van Kooten TG, Koopmans SA. Prevention of posterior capsular opacification. Exp Eye Res. 2015; 136: 100–115.
Wormstone IM, Wang L, Liu CS. Posterior capsule opacification. Exp Eye Res. 2009; 88: 257–269.
de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 2005; 179: 43–55.
Saika S. TGFbeta pathobiology in the eye. Lab Invest. 2006; 86: 106–115.
Gordon-Thomson C, de Iongh RU, Hales AM, Chamberlain CG, McAvoy JW. Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye. Invest Ophthalmol Vis Sci. 1998; 39: 1399–1409.
Saika S, Yamanaka O, Sumioka T, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res. 2008; 27: 177–196.
Walker J, Menko AS. Integrins in lens development and disease. Exp Eye Res. 2009; 88: 216–225.
Sponer U, Pieh S, Soleiman A, Skorpik C. Upregulation of alphavbeta6 integrin, a potent TGF-beta1 activator, and posterior capsule opacification. J Cataract Refract Surg. 2005; 31: 595–606.
Todorovic V, Jurukovski V, Chen Y, Fontana L, Dabovic B, Rifkin DB. Latent TGF-beta binding proteins. Int J Biochem Cell Biol. 2005; 37: 38–41.
Liu J, Hales AM, Chamberlain CG, McAvoy JW. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor beta. Invest Ophthalmol Vis Sci. 1994; 35: 388–401.
Hales AM, Chamberlain CG, McAvoy JW. Susceptibility to TGFbeta2-induced cataract increases with aging in the rat. Invest Ophthalmol Vis Sci. 2000; 41: 3544–3551.
Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci. 2002; 43: 2301–2308.
Wormstone IM, Tamiya S, Eldred JA, et al. Characterisation of TGF-beta2 signalling and function in a human lens cell line. Exp Eye Res. 2004; 78: 705–714.
Li J, Tang X, Chen X. Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. Exp Eye Res. 2011; 92: 173–179.
Lin H, Ouyang H, Zhu J, et al. Lens regeneration using endogenous stem cells with gain of visual function. Nature. 2016; 531: 323–328.
Ibaraki N. Human lens epithelial cell culture. Methods Mol Biol. 2002; 188: 1–6.
Andley UP, Rhim JS, Chylack LT, Fleming TP. Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci. 1994; 35: 3094–3102.
Ibaraki N, Lin LR, Reddy VN. Effects of growth factors on proliferation and differentiation in human lens epithelial cells in early subculture. Invest Ophthalmol Vis Sci. 1995; 36: 2304–2312.
Power W, Neylan D, Collum L. Growth characteristics of human lens epithelial cells in culture. Effect of media and donor age. Doc Ophthalmol. 1993; 84: 365–372.
Liu H, Feng G, Wu L, et al. The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: an in vitro study. Mol Vis. 2010; 16: 1646–1653.
Liu CS, Wormstone IM, Duncan G, Marcantonio JM, Webb SF, Davies PD. A study of human lens cell growth in vitro. A model for posterior capsule opacification. Invest Ophthalmol Vis Sci. 1996; 37: 906–914.
Kubo E, Shibata S, Shibata T, Kiyokawa E, Sasaki H, Singh DP. FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity. J Cell Mol Med. 2017; 21: 916–928.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3: 1101–1108.
McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle. 2014; 13: 1400–1412.
Rueden CT, Schindelin J, Hiner MC, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017; 18: 529.
Lambert SR, Drack AV. Infantile cataracts. Surv Ophthalmol. 1996; 40: 427–458.
Wormstone IM, Eldred JA. Experimental models for posterior capsule opacification research. Exp Eye Res. 2016; 142: 2–12.
Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009; 19: 156–172.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15: 178–196.
Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009; 19: 128–139.
Lovicu FJ, Schulz MW, Hales AM, et al. TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract. Br J Ophthalmol. 2002; 86: 220–226.
Gotoh N, Perdue NR, Matsushima H, Sage EH, Yan Q, Clark JI. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium. Invest Ophthalmol Vis Sci. 2007; 48: 4679–4687.
Lee EH, Joo CK. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells. Invest Ophthalmol Vis Sci. 1999; 40: 2025–2032.
Fontana L, Chen Y, Prijatelj P, et al. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 2005; 19: 1798–1808.
Olivero DK, Furcht LT. Type IV collagen, laminin, and fibronectin promote the adhesion and migration of rabbit lens epithelial cells in vitro. Invest Ophthalmol Vis Sci. 1993; 34: 2825–2834.
Johar K, Vasavada AR, Tatsumi K, Dholakia S, Nihalani B, Rao SS. Anterior capsular plaque in congenital cataract: occurrence, morphology, immunofluorescence, and ultrastructure. Invest Ophthalmol Vis Sci. 2007; 48: 4209–4214.
Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol. 2004; 172: 7123–7135.
Ramirez F, Tanaka S, Bou-Gharios G. Transcriptional regulation of the human alpha2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases. Matrix Biol. 2006; 25: 365–372.
Raghavan CT, Smuda M, Smith AJ, et al. AGEs in human lens capsule promote the TGFβ2-mediated EMT of lens epithelial cells: implications for age-associated fibrosis. Aging Cell. 2016; 15: 465–476.
Nagamoto T, Eguchi G, Beebe DC. Alpha-smooth muscle actin expression in cultured lens epithelial cells. Invest Ophthalmol Vis Sci. 2000; 41: 1122–1129.
Jong-Hesse YD, Lang GK, Kampmeier J, Lang GE. Effect of growth factors on the differentiation of porcine lens epithelial cells [in German]. Klin Monbl Augenheilkd. 2004; 221: 175–179.
Xiao Y, Zhao B, Gao Z, Pan Q. Overaccumulation of transforming growth factor-beta1 and basic fibroblast growth factor in lens epithelial cells of congenital cataract. Can J Ophthalmol. 2009; 44: 189–192.
Banasiak P, Strzalka-Mrozik B, Forminska-Kapuscik M, et al. Quantitative relationships between transforming growth factor beta mRNA isoforms in congenital and traumatic cataracts. Mol Vis. 2011; 17: 3025–3033.
Saika S, Miyamoto T, Ishida I, et al. TGFbeta-Smad signalling in postoperative human lens epithelial cells. Br J Ophthalmol. 2002; 86: 1428–1433.
Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002; 29: 23–39.
Valasek MA, Repa JJ. The power of real-time PCR. Adv Physiol Educ. 2005; 29: 151–159.
Andley UP. Effects of alpha-crystallin on lens cell function and cataract pathology. Curr Mol Med. 2009; 9: 887–892.
Horwitz J, Bova MP, Ding LL, Haley DA, Stewart PL. Lens alpha-crystallin: function and structure. Eye (Lond). 1999; 13: 403–408.
Nahomi RB, Pantcheva MB, Nagaraj RH. αB-crystallin is essential for the TGF-β2-mediated epithelial to mesenchymal transition of lens epithelial cells. Biochem J. 2016; 473: 1455–1469.
Liu M, Ke T, Wang Z, et al. Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci. 2006; 47: 3461–3466.
Bellaye PS, Wettstein G, Burgy O, et al. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis. J Pathol. 2014; 232: 458–472.
Andley UP. Crystallins in the eye: function and pathology. Prog Retin Eye Res. 2007; 26: 78–98.
Figure 1
 
Gene expression profile of pediatric lens cells. (A) Manual capsulorhexis during cataract surgery on a child. The anterior lens capsule with the attached primary lens epithelial cells is harvested. (B) Cultivated pLEC were monitored by phase contrast microscopy on day 6 (objective ×20). Cells near the capsule were predominantly cuboid, whereas remote cells had an elongated character. (C) Quantitative RT-PCR was used to analyze mRNA expression for Cx43, CRYAB, aSMA, ITGAV, COL1A2, and FN1. TGFβ-2 (10 ng/mL for 48 hours) increased gene expression of COL1A2 and FN1 significantly (P < 0.05) in pLEC. GAPDH was selected as housekeeping gene. p0, passage 0; p2, passage 2.
Figure 1
 
Gene expression profile of pediatric lens cells. (A) Manual capsulorhexis during cataract surgery on a child. The anterior lens capsule with the attached primary lens epithelial cells is harvested. (B) Cultivated pLEC were monitored by phase contrast microscopy on day 6 (objective ×20). Cells near the capsule were predominantly cuboid, whereas remote cells had an elongated character. (C) Quantitative RT-PCR was used to analyze mRNA expression for Cx43, CRYAB, aSMA, ITGAV, COL1A2, and FN1. TGFβ-2 (10 ng/mL for 48 hours) increased gene expression of COL1A2 and FN1 significantly (P < 0.05) in pLEC. GAPDH was selected as housekeeping gene. p0, passage 0; p2, passage 2.
Figure 2
 
Frequency distribution of properties of all collected capsules versus capsules with outgrowth of pLEC. (A) Effect of age at time of surgery on outgrowth of pLEC in culture. Of capsules showing cell growth, 69% came from children 12 months or younger, 25% of children aged 13–60 months, and the remaining 6% from children older than 60 months. (B) Effect of cataract etiology on outgrowth of pLEC in culture. (C) Effect of clinical type of cataract on outgrowth of pLEC in culture. APC, anterior polar cataract; CC, complex cataract; NOS, not otherwise specified; PFV, persistent fetal vasculature; PPC, posterior polar cataract; PSC, posterior subcapsular cataract; TC, total cataract; ZC, zonular cataract.
Figure 2
 
Frequency distribution of properties of all collected capsules versus capsules with outgrowth of pLEC. (A) Effect of age at time of surgery on outgrowth of pLEC in culture. Of capsules showing cell growth, 69% came from children 12 months or younger, 25% of children aged 13–60 months, and the remaining 6% from children older than 60 months. (B) Effect of cataract etiology on outgrowth of pLEC in culture. (C) Effect of clinical type of cataract on outgrowth of pLEC in culture. APC, anterior polar cataract; CC, complex cataract; NOS, not otherwise specified; PFV, persistent fetal vasculature; PPC, posterior polar cataract; PSC, posterior subcapsular cataract; TC, total cataract; ZC, zonular cataract.
Figure 3
 
Effects of TGFβ-2 on HLE-B3 cells. (A) Phase contrast microscopy of cell line HLE-B3 in passage 5 (objective ×20). Scale bar: 1 mm. (B) Relative mRNA expression of all investigated genes in absence and presence of 10 ng/mL TGFβ-2. CRYAB, ITGAV, COL1A2, and FN1 were significantly increased after stimulation with TGFβ-2 for 48 hours (P < 0.05).
Figure 3
 
Effects of TGFβ-2 on HLE-B3 cells. (A) Phase contrast microscopy of cell line HLE-B3 in passage 5 (objective ×20). Scale bar: 1 mm. (B) Relative mRNA expression of all investigated genes in absence and presence of 10 ng/mL TGFβ-2. CRYAB, ITGAV, COL1A2, and FN1 were significantly increased after stimulation with TGFβ-2 for 48 hours (P < 0.05).
Figure 4
 
Immunocytochemistry of HLE-B3 cells. Immunocytochemistry of HLE-B3 cells stained with antibodies against αSMA (A) and FN (B) in absence and presence of 10 ng/mL TGFβ-2. Nuclei were stained with DAPI. Mean corrected cell fluorescence of FN was significantly increased by TGFβ-2 (C), P < 0.05. Scale bar: 50 μm.
Figure 4
 
Immunocytochemistry of HLE-B3 cells. Immunocytochemistry of HLE-B3 cells stained with antibodies against αSMA (A) and FN (B) in absence and presence of 10 ng/mL TGFβ-2. Nuclei were stained with DAPI. Mean corrected cell fluorescence of FN was significantly increased by TGFβ-2 (C), P < 0.05. Scale bar: 50 μm.
Figure 5
 
Fold expression of unstimulated primary pLEC and unstimulated HLE-B3 cells. (A) Fold expression of COL1A2, CRYAB, and aSMA are up to 194-fold higher in primary pLEC (p0) compared to HLE-B3. mRNA expression of Cx43 and ITGAV are up to 4-fold higher in primary pLEC compared to HLE-B3, while expression of FN1 was lower in primary pLEC (p0). mRNA expression of HLE-B3 was normalized to 1. (B) Relative mRNA expression of TGFβ-2 was significant higher in primary isolated pLEC (p0) compared to HLE-B3 cells (P < 0.05).
Figure 5
 
Fold expression of unstimulated primary pLEC and unstimulated HLE-B3 cells. (A) Fold expression of COL1A2, CRYAB, and aSMA are up to 194-fold higher in primary pLEC (p0) compared to HLE-B3. mRNA expression of Cx43 and ITGAV are up to 4-fold higher in primary pLEC compared to HLE-B3, while expression of FN1 was lower in primary pLEC (p0). mRNA expression of HLE-B3 was normalized to 1. (B) Relative mRNA expression of TGFβ-2 was significant higher in primary isolated pLEC (p0) compared to HLE-B3 cells (P < 0.05).
Table 1
 
Primer Sequences Used for mRNA Quantification by qRT-PCR
Table 1
 
Primer Sequences Used for mRNA Quantification by qRT-PCR
Table 2
 
Characteristics of 40 Child Study Participants With Cataracts
Table 2
 
Characteristics of 40 Child Study Participants With Cataracts
Table 3
 
Properties of the Capsules Included in the Study Regarding Patients' Features
Table 3
 
Properties of the Capsules Included in the Study Regarding Patients' Features
Supplement 1
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×